Showing results (1-10 of 88) with videos related to
Sort By:
Pageof 9
F1000Research|January 21, 2017
Recent advances in understanding antiphospholipid syndromeMaria Laura Bertolaccini, Giovanni SannaSeminars in Thrombosis and Hemostasis|May 5, 2017
The Clinical Relevance of Noncriteria Antiphospholipid AntibodiesMaria Laura Bertolaccini, Giovanni SannaCurrent Pharmaceutical Design|June 10, 2008
Neuropsychiatric involvement in systemic lupus erythematosus: current therapeutic approachGiovanni Sanna, Maria Laura Bertolaccini, Munther A KhamashtaAnnals of the New York Academy of Sciences|August 30, 2005
Hughes syndrome, the antiphospholipid syndrome: a new chapter in neurologyGiovanni Sanna, Maria Laura Bertolaccini, Graham R V HughesF1000Research|July 21, 2018
Recent advances in the management of systemic lupus erythematosusSavino Sciascia, Massimo Radin, Dario Roccatello, et al.Autoimmunity Reviews|September 7, 2012
The clinical relevance of IgA anticardiolipin and IgA anti-β2 glycoprotein I antiphospholipid antibodies: a systematic reviewHector Meijide, Savino Sciascia, Giovanni Sanna, et al.Thrombosis Research|December 18, 2013
Validation of a commercially available kit to detect anti-phosphatidylserine/prothrombin antibodies in a cohort of systemic lupus erythematosus patientsSavino Sciascia, Giovanni Sanna, Veronica Murru, et al.Journal of Neurology|June 22, 2014
Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic reviewSavino Sciascia, Maria Laura Bertolaccini, Dario Roccatello, et al.Rheumatology (Oxford, England)|January 18, 2018
Clinical utility of the global anti-phospholipid syndrome score for risk stratification: a pooled analysisSavino Sciascia, Massimo Radin, Giovanni Sanna, et al.Annals of the Rheumatic Diseases|October 6, 2006
Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosusMaria Laura Bertolaccini, Kirti Mepani, Giovanni Sanna, et al.Pageof 9